M&A Deal Summary

Covidien Acquires VNUS Medical Technologies

On May 8, 2009, Covidien acquired medical products company VNUS Medical Technologies for 440M USD

Acquisition Highlights
  • This is Covidien’s 4th transaction in the Medical Products sector.
  • This is Covidien’s 4th largest (disclosed) transaction.
  • This is Covidien’s 4th transaction in the United States.
  • This is Covidien’s 1st transaction in California.

M&A Deal Summary
Date 2009-05-08
Target VNUS Medical Technologies
Sector Medical Products
Buyer(s) Covidien
Deal Type Add-on Acquisition
Deal Value 440M USD

Target

VNUS Medical Technologies

San Jose, California, United States
website
VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Covidien

Dublin, Ireland

website

Category Company
Sector Medical Products
Employees38,500
Revenue 10.2B USD (2013)
DESCRIPTION
Covidien office in Plymouth, Minnesota.
Covidien office in Plymouth, Minnesota.

Covidien plc is a global healthcare technology and medical supplies provider. Covidien was formed as a spin-off from Tyco in 2007 and is based in Dublin, Ireland.

DEAL STATS #
Overall 5 of 21
Sector (Medical Products) 4 of 15
Type (Add-on Acquisition) 3 of 17
State (California) 1 of 8
Country (United States) 4 of 16
Year (2009) 1 of 2
Size (of disclosed) 4 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-11-08 Scandius BioMedical

Littleton, Massachusetts, United States

Scandius BioMedical, Inc. headquartered in Littleton, Massachusetts, designs, manufactures, and markets products for the orthopedic sports medicine market. The Company is focused on accelerating innovative solutions for minimally invasive orthopedic sports medicine procedures. With its STRATIS? ACL Femoral Fixation Implant and its TriTis? Tibial Fixation System and Implant the Company is able to offer surgeons a complete solution for their soft tissue ACL reconstruction needs. Both technologies offer surgeons a simplified approach to repairing the single most common sports-related orthopedic joint injury - the reconstruction of a torn anterior cruciate ligament. Scandius maintains a strong R&D pipeline focused on procedure specific products that treat a variety of sports-related injuries, with future developments addressing the areas of meniscal repair, articular cartilage and arthroscopic shoulder surgery.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-06 Aspect Medical Systems

Norwood, Massachusetts, United States

Aspect Medical Systems, Inc. a market leader in brain monitoring technology. Aspect's Bispectral Index technology directly measures the effects of anesthetics and sedatives on the brain and has been used to assess more than 7.5 million patients.

Buy $210M
Mergr

Product

Company

Legal